CORD-19:4abc50cfc81265083d4cb2aed0a493bb704d0b5b / 35414-35659 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/4abc50cfc81265083d4cb2aed0a493bb704d0b5b","sourcedb":"CORD-19","sourceid":"4abc50cfc81265083d4cb2aed0a493bb704d0b5b","text":"Other advantages of nucleic acid-based vaccines include stability, low production costs, ease of development and purification, and scaling up of production being much simpler compared to that of purified protein vaccines or viral vaccines [69] .","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T174","span":{"begin":0,"end":245},"obj":"Sentence"},{"id":"T37121","span":{"begin":0,"end":245},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T174","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T37121","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93eca3","default":true}]}]}}